Yara International ASA

DB:IU2 Stock Report

Market Cap: €6.7b

Yara International Valuation

Is IU2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IU2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IU2 (€25.95) is trading above our estimate of fair value (€20.49)

Significantly Below Fair Value: IU2 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IU2?

Key metric: As IU2 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IU2. This is calculated by dividing IU2's market cap by their current earnings.
What is IU2's PE Ratio?
PE Ratio12.5x
EarningsUS$548.00m
Market CapUS$6.83b

Price to Earnings Ratio vs Peers

How does IU2's PE Ratio compare to its peers?

The above table shows the PE ratio for IU2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.9x
SDF K+S
75.1x57.3%€1.9b
EVK Evonik Industries
34x33.0%€7.8b
FPE3 Fuchs
18.3x8.6%€4.8b
WCH Wacker Chemie
28.1x36.6%€3.5b
IU2 Yara International
12.5x14.2%€77.7b

Price-To-Earnings vs Peers: IU2 is good value based on its Price-To-Earnings Ratio (12.5x) compared to the peer average (38.9x).

Price to Earnings Ratio vs Industry

How does IU2's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
IU2 12.5xIndustry Avg. 17.5xNo. of Companies11PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IU2 is good value based on its Price-To-Earnings Ratio (12.5x) compared to the European Chemicals industry average (17.5x).

Price to Earnings Ratio vs Fair Ratio

What is IU2's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IU2 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.5x
Fair PE Ratio16.7x

Price-To-Earnings vs Fair Ratio: IU2 is good value based on its Price-To-Earnings Ratio (12.5x) compared to the estimated Fair Price-To-Earnings Ratio (16.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IU2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€25.95
€29.91
+15.3%
15.2%€36.90€21.21n/a20
Dec ’25€26.53
€30.08
+13.4%
14.8%€37.25€21.41n/a18
Nov ’25€27.66
€29.24
+5.7%
15.2%€36.30€20.86n/a18
Oct ’25€28.54
€29.56
+3.6%
14.8%€37.03€23.83n/a17
Sep ’25€26.40
€29.57
+12.0%
15.0%€37.11€23.03n/a17
Aug ’25€26.13
€29.79
+14.0%
15.6%€36.81€22.85n/a17
Jul ’25€26.74
€30.79
+15.1%
16.4%€38.04€23.61n/a17
Jun ’25€28.64
€31.16
+8.8%
15.8%€38.21€23.72n/a17
May ’25€26.91
€31.34
+16.5%
14.6%€37.92€23.66n/a17
Apr ’25€29.33
€32.57
+11.0%
11.7%€37.52€25.63n/a17
Mar ’25€29.88
€33.87
+13.4%
11.6%€38.16€26.31n/a17
Feb ’25€30.90
€33.95
+9.9%
14.5%€40.53€22.91n/a16
Jan ’25€32.09
€35.45
+10.5%
13.3%€42.35€26.75€25.3816
Dec ’24€31.20
€34.44
+10.4%
13.4%€40.94€25.86€26.5316
Nov ’24€30.88
€34.09
+10.4%
12.8%€40.19€27.08€27.6616
Oct ’24€36.00
€36.79
+2.2%
13.1%€44.65€28.30€28.5417
Sep ’24€33.86
€35.87
+5.9%
13.4%€43.91€27.83€26.4018
Aug ’24€36.69
€36.69
+0.005%
13.2%€45.04€28.54€26.1318
Jul ’24€32.47
€36.99
+13.9%
13.2%€44.40€28.17€26.7418
Jun ’24€35.13
€37.14
+5.7%
12.8%€44.14€29.43€28.6418
May ’24€36.95
€38.75
+4.9%
13.4%€45.83€30.55€26.9118
Apr ’24€39.99
€41.59
+4.0%
12.4%€48.45€31.71€29.3318
Mar ’24€44.15
€43.76
-0.9%
11.2%€49.68€32.52€29.8817
Feb ’24€41.00
€43.71
+6.6%
10.5%€51.41€34.89€30.9017
Jan ’24€41.09
€45.29
+10.2%
11.4%€53.39€36.23€32.0917

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:41
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yara International ASA is covered by 62 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Andrew BensonÅlandsbanken Equities Research Ab
Stephen WilderAlliance Global Partners